SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 163 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $37,763,000 | +9.0% | 8,524,295 | +14.9% | 0.01% | 0.0% |
Q3 2016 | $34,641,000 | -11.8% | 7,417,828 | +24.1% | 0.01% | -22.2% |
Q2 2016 | $39,275,000 | +3.8% | 5,977,977 | +0.5% | 0.01% | 0.0% |
Q1 2016 | $37,820,000 | +5.6% | 5,946,607 | +0.1% | 0.01% | +12.5% |
Q4 2015 | $35,809,000 | +2.2% | 5,938,486 | +1.4% | 0.01% | -11.1% |
Q3 2015 | $35,033,000 | -14.5% | 5,858,369 | -2.2% | 0.01% | -10.0% |
Q2 2015 | $40,961,000 | +21.5% | 5,988,521 | +7.8% | 0.01% | +25.0% |
Q1 2015 | $33,723,000 | -9.1% | 5,555,649 | +3.8% | 0.01% | -11.1% |
Q4 2014 | $37,095,000 | -3.8% | 5,352,842 | +13.0% | 0.01% | -18.2% |
Q3 2014 | $38,545,000 | +2.8% | 4,735,291 | +2.6% | 0.01% | 0.0% |
Q2 2014 | $37,505,000 | +19.1% | 4,613,164 | +14.8% | 0.01% | +22.2% |
Q1 2014 | $31,492,000 | -17.8% | 4,016,808 | -7.2% | 0.01% | -25.0% |
Q4 2013 | $38,320,000 | +9.7% | 4,329,961 | +3.9% | 0.01% | 0.0% |
Q3 2013 | $34,918,000 | +28.7% | 4,166,811 | +14.5% | 0.01% | +20.0% |
Q2 2013 | $27,138,000 | – | 3,637,843 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
CM Management, LLC | 600,000 | $468,000 | 0.50% |
ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
Ergoteles LLC | 744,275 | $581,000 | 0.02% |
Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |